EGFR and neoplasm: Examining the efficacy of combining PDT with the EGFR inhibitor nimotuzumab in OSCC, Bhuvaneswari R. et al. showed synergistic effects in delaying tumor growth, downregulating EGFR, and demonstrating no treatment-related toxicity [160].